Inability of nih, fda, to identify conflict of interest, Operation Research

Inability of NIH, FDA, to Identify Conflict of Interest

While federal regulations require that researchers receiving NIH grants remain free of financial conflicts of interest, NIH relies on the academic institutions to gather financial information from grant investigators and to manage or eliminate conflicts of interest, but does not require universities to provide information about the conflicts or how they are resolved. Indeed, a report of the inspector general of the Department of Health and Human Services concedes NIH does not know the number or nature of conflicts of interest and does not track how universities and other institutions resolved them. The FDA may be faring no better than NIH. The Office of Inspector General of the U.S. Department of Health and Human Services audited the financial disclosures made by researchers in "all 118 marketing applications approved by the FDA in the 2007 fiscal year," determined that "[o]nly 1 percent of clinical investigators disclosed a financial interest in the products they studied," and concluded that "[c]linical investigators may not be disclosing all financial interests." As noted above, the Harvard University survey of U.S. doctors determined that 28% of doctors were paid for consulting, giving lectures, or signing up patients for clinical trials, and the AMA survey determined that 27% of medical school department heads worked as paid consultants. Most universities rely on their professors to report financial information, but lack the wherewithal to verify the information they submit. Only a handful of states and the District of Columbia require some level of disclosure of pharmaceutical company payments to physicians. There is no database which universities can use to check the disclosures made by physicians to their academic institutions or which informs the public of the fees paid by drug companies to physicians for consulting, speeches, and clinical trials. 

Posted Date: 2/26/2013 6:35:18 AM | Location : United States







Related Discussions:- Inability of nih, fda, to identify conflict of interest, Assignment Help, Ask Question on Inability of nih, fda, to identify conflict of interest, Get Answer, Expert's Help, Inability of nih, fda, to identify conflict of interest Discussions

Write discussion on Inability of nih, fda, to identify conflict of interest
Your posts are moderated
Related Questions
Deriving the Solution from the Model: This phase is devoted to the computation of those value of decision variables that maximize or minimize the objective function. Such

a. Determine the following with respect to decision making approaches: (i) Group decision making (ii) Directive, analytic, conceptual and behavioral decision making styles (8

marginal rate of substitution, degeneracy and degenerate solution

Characteristics  of Good Average a. It should  be Rigidly  Defined  An average should  be rigidly defined so that  there is  no confusion  in regard  to its  meaning  and con

Classification of documents by information Characteristics: The schemes of classification advocated by Hanson and Grogan are mainly based on the information characteristics of

A paper mill produces two grades of paper viz., X and Y. Because of raw material restrictions, it cannot produce more than 400 tons of grade X paper and 300 tons of grade Y paper i

Importance of Normal Distribution Normal distribution  plays  a very  important  role in  statistical  theory  and in  particular  in sampling theory. It has  been  found  th

Edwards Life Sciences is trying to decide if it should sell a new type of medical product. Fixed costs associated to the production of the product are estimated to be $30,000. Th

Show simple vapour compression Refrigeration cycle with showing all the devices and also draw T-sand P-R diagram and illustrate it also. A Bell-Coleman cycle works between 1 bar

This assignment requires you to evaluate a product from the view point of quality, both quality of design (as perceived by the user) and quality of conformance. To ensure that we a